Table 2.
Characteristics of extracutaneous involvement.
| Characteristics | Patient number | Percentage (%) |
|---|---|---|
| Extracutaneous involvement | 58 | 81 |
| Chest | 56 | 97 |
| Stage 1 | 25 | 43 |
| Stage 2 | 21 | 36 |
| Stage 3 | 2 | 3 |
| Stage 4 | 8 | 14 |
| Kidney | 8 | 14 |
| Extrathoracic lymphadenopathy | 8 | 14 |
| Ocular | 7 | 12 |
| Heart | 2 | 3 |
| Hepatic | 1 | 2 |
| Spleen | 1 | 2 |
| Pancreas | 1 | 2 |
| Gastrointestinal tract | 1 | 2 |
| Muscles | 1 | 2 |
| Upper respiratory tract | 1 | 2 |
| Articular | 1 | 2 |
| Bones | 1 | 2 |
| First manifestation | ||
| Cutaneous | 43 | 74 |
| Extracutaneous | 15 | 26 |